SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-021894
Filing Date
2022-08-10
Accepted
2022-08-10 16:16:01
Documents
51
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 782533
2 ex31-1.htm EX-31.1 16579
3 ex31-2.htm EX-31.2 16588
4 ex32-1.htm EX-32.1 8052
5 ex32-2.htm EX-32.2 7957
  Complete submission text file 0001493152-22-021894.txt   4289780

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE foxw-20220630.xsd EX-101.SCH 35373
7 XBRL CALCULATION FILE foxw-20220630_cal.xml EX-101.CAL 36975
8 XBRL DEFINITION FILE foxw-20220630_def.xml EX-101.DEF 193315
9 XBRL LABEL FILE foxw-20220630_lab.xml EX-101.LAB 265870
10 XBRL PRESENTATION FILE foxw-20220630_pre.xml EX-101.PRE 224221
45 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 672184
Mailing Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020 917-284-8938
FoxWayne Enterprises Acquisition Corp. (Filer) CIK: 0001829999 (see all company filings)

IRS No.: 853093926 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39891 | Film No.: 221152035
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences